SCHEMBL568863

SCHEMBL568863

NC(=O)Nc1ccsc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28723714 0.83 HPGD (0.42)
SCHEMBL29473470 0.81 HPGD (0.47)
SCHEMBL3280929 0.79
SCHEMBL4131287 0.77
SCHEMBL7438683 0.77
SCHEMBL8847816 0.77
SCHEMBL17082813 0.77
SCHEMBL568862 0.77
SCHEMBL28472008 0.77 HPGD (0.53)
SCHEMBL5062623 0.75 PEPD (0.80)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111526877-B Compounds and compositions for IRE1 inhibition 奥普提卡拉公司 2023-08-25 CN claimed
US-9974795-B2 Anticancer agent composition CARNA BIOSCIENCES, INC. (JP) 2018-05-22 US claimed
US-20170065609-A1 ANTICANCER AGENT COMPOSITION CARNA BIOSCIENCES, INC. (JP) 2017-03-09 US claimed
EP-3100742-A1 ANTICANCER AGENT COMPOSITION Carna Biosciences Inc. (JP) 2016-12-07 EP claimed
CN-102725292-A Imidazopyridine compounds as novel constructs for multi-target kinase inhibition ABBOTT LAB 2012-10-10 CN claimed
US-20100143332-A1 COMBINATION THERAPY FOR PROLIFERATIVE DISORDERS SCHERING CORPORATION 2010-06-10 US claimed
CN-101027294-A Phenyl DIAZEPAN carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine D3 antagonists SANOL ARZNEI SCHWARZ GMBH (DE) 2007-08-29 CN claimed
CN-112300172-B Bruton tyrosine kinase inhibitors 比奥根MA公司 2024-01-16 CN disclosed
CN-111526877-B Compounds and compositions for IRE1 inhibition 奥普提卡拉公司 2023-08-25 CN disclosed
CN-111018829-B 4-alkyl-thio-polysubstituted thiophene derivative and synthesis thereof 中国科学院大连化学物理研究所 2022-10-04 CN disclosed
CN-114222739-A Sulfonylurea derivatives and use thereof 诺瑟拉有限公司 2022-03-22 CN disclosed
US-11147800-B2 Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof RACE ONCOLOGY LTD. (AU) 2021-10-19 US disclosed
US-11135201-B2 Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof RACE ONCOLOGY LTD. (AU) 2021-10-05 US disclosed
WO-2005066163-A2 THIOPHENE DERIVATIVES AS CHK 1 INIHIBITORS ASTRAZENECA AB (SE) 2005-07-21 WO disclosed
CN-1589153-A Prevention or treatment of urinary disorders TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2005-03-02 CN disclosed
WO-2003028731-A1 CHK1 KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-04-10 WO disclosed
US-5776981-A Use of acyl urea compounds for controlling endoparasites and ectoparasites of warm-blooded animals NOVARTIS CORPORATION (US) 1998-07-07 US disclosed
US-5776982-A Use of acyl urea compounds for controlling endoparasites and ectoparasites of warm-blooded animals NOVARTIS CORPORATION (US) 1998-07-07 US disclosed
US-5135953-A Oral or injections; cattle, swine, poultry CIBA-GEIGY (US) 1992-08-04 US disclosed
US-4053484-A 1-Benzoyl-3-(4,5,6,7-tetrahydrobenzo [b]thien-4-yl)ureas and 1-benzoyl-3-(4,5,6,7-tetrahydro-7-oxobenzo [b]thien-4-yl)ureas, novel intermediates for the preparation of animal growth promoting agents AMERICAN CYANAMID COMPANY (US) 1977-10-11 US disclosed